Recursion Pharmaceuticals, Inc. (RXRX) — Analyst estimates
Consensus analyst estimates for Recursion Pharmaceuticals, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 24.79M | -0.22 | 2 |
| 2027 | 36.13M | -0.2 | 2 |
| 2028 | 5.20M | -0.21 | 3 |
| 2029 | 247.5M | -0.94 | 1 |
Consensus analyst estimates by fiscal year.